161 related articles for article (PubMed ID: 35542895)
1. Epidemiology, management, and outcomes of atrial fibrillation among 30 million citizens in Shanghai, China from 2015 to 2020: A medical insurance database study.
Chen M; Li C; Liao P; Cui X; Tian W; Wang Q; Sun J; Yang M; Luo L; Wu H; Li YG
Lancet Reg Health West Pac; 2022 Jun; 23():100470. PubMed ID: 35542895
[TBL] [Abstract][Full Text] [Related]
2. Cancer and Atrial Fibrillation Comorbidities Among 25 Million Citizens in Shanghai, China: Medical Insurance Database Study.
Chen M; Li C; Zhang J; Cui X; Tian W; Liao P; Wang Q; Sun J; Luo L; Wu H; Li YG
JMIR Public Health Surveill; 2023 Oct; 9():e40149. PubMed ID: 37847541
[TBL] [Abstract][Full Text] [Related]
3. The WATCHMAN left atrial appendage closure device for atrial fibrillation.
Möbius-Winkler S; Sandri M; Mangner N; Lurz P; Dähnert I; Schuler G
J Vis Exp; 2012 Feb; (60):. PubMed ID: 22395336
[TBL] [Abstract][Full Text] [Related]
4. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
[TBL] [Abstract][Full Text] [Related]
5. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
[TBL] [Abstract][Full Text] [Related]
7. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.
Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE
Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184
[TBL] [Abstract][Full Text] [Related]
8. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
Guo Y; Wang H; Tian Y; Wang Y; Lip GYH
Chest; 2015 Jul; 148(1):62-72. PubMed ID: 25501045
[TBL] [Abstract][Full Text] [Related]
9. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).
Lip GY; Laroche C; Ioachim PM; Rasmussen LH; Vitali-Serdoz L; Petrescu L; Darabantiu D; Crijns HJ; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP; Boriani G
Eur Heart J; 2014 Dec; 35(47):3365-76. PubMed ID: 25176940
[TBL] [Abstract][Full Text] [Related]
10. Advanced electrophysiologic mapping systems: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
[TBL] [Abstract][Full Text] [Related]
12. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
Reddy VY; Möbius-Winkler S; Miller MA; Neuzil P; Schuler G; Wiebe J; Sick P; Sievert H
J Am Coll Cardiol; 2013 Jun; 61(25):2551-6. PubMed ID: 23583249
[TBL] [Abstract][Full Text] [Related]
13. Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program.
Mazurek M; Huisman MV; Rothman KJ; Paquette M; Teutsch C; Diener HC; Dubner SJ; Halperin JL; Zint K; França LR; Lu S; Lip GYH;
Am J Med; 2018 Aug; 131(8):945-955.e3. PubMed ID: 29654720
[TBL] [Abstract][Full Text] [Related]
14. Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
Holmqvist F; Simon D; Steinberg BA; Hong SJ; Kowey PR; Reiffel JA; Naccarelli GV; Chang P; Gersh BJ; Peterson ED; Piccini JP;
J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25999401
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.
Freeman JV; Shrader P; Pieper KS; Allen LA; Chan PS; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel JA; Singer DE; Go AS; Hylek EM; Steinberg BA; Peterson ED; Piccini JP
Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007612. PubMed ID: 31830822
[TBL] [Abstract][Full Text] [Related]
16. Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
Gloekler S; Saw J; Koskinas KC; Kleinecke C; Jung W; Nietlispach F; Meier B
Int J Cardiol; 2017 Dec; 249():234-246. PubMed ID: 28882323
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ
Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy for atrial fibrillation in elderly hospitalized patients with comorbid congestive heart failure in australia: A retrospective study.
Wang L; Curran S; Ball P; White F
Curr Ther Res Clin Exp; 2008 Dec; 69(6):514-24. PubMed ID: 24692825
[TBL] [Abstract][Full Text] [Related]
19. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
[TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke.
Masjuan J; Salido L; DeFelipe A; Hernández-Antolín R; Fernández-Golfín C; Cruz-Culebras A; Matute C; Vera R; Pérez-Torre P; Zamorano JL
Eur J Neurol; 2019 May; 26(5):816-820. PubMed ID: 30586229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
